UT Southwestern Home

The PillCam goes on a fantastic voyage to help diagnose GI bleeding | Digestive | UT Southwestern Medical Center

https://utswmed.org/medblog/pillcam-gets-close-and-intestinal-spot-gi-bleeding/

The PillCam may sound like something out of a sci-fi film: You swallow it and it takes thousands of pictures of your insides. But the PillCam, or capsule endoscopy, is actually a powerful diagnostic tools that UT Southwestern GI specialists will be using at the new medical center in Frisco, when it

Mishkah Vayda, M.P.A.S., PA-C: Internal Medicine | UT Southwestern Medical Center

https://utswmed.org/doctors/mishkah-vayda/

Mishkah Vayda, M.P.A.S., PA-C, is in the Division of Internal Medicine - Pulmonary Disease at UT Southwestern Medical Center.

Hanine El Haddad, M.D.: Internal Medicine | Infectious Diseases in Immunocompromised Patients | UT Southwestern Medical Center

https://utswmed.org/doctors/hanine-el-haddad/

Hanine El Haddad, M.D., FIDSA, is an Associate Professor of Internal Medicine at UT Southwestern Medical Center; she specializes in infectious diseases.

Life after coronavirus: PM&R helps patients beat muscle weakness, brain fog | Brain | COVID | Rehabilitation | UT Southwestern Medical Center

https://utswmed.org/medblog/life-after-coronavirus-how-rehab-helps/

After COVID-19 infection, many patients struggle with "brain fog" and muscle weakness. See how custom Physical Medicine & Rehabilitation care can improve patients' long-term health.

Melissa Panter, M.S.N., APRN, AGACNP-BC: Neurology | UT Southwestern Medical Center

https://utswmed.org/doctors/melissa-panter/

Melissa Panter, M.S.N., APRN, AGACNP-BC, is in the Division of Neurology at UT Southwestern Medical Center.

Immunotherapy and the marathon against melanoma: Terry's story | Cancer | Discovery | Patient Stories | UT Southwestern Medical Center

https://utswmed.org/medblog/immunotherapy-metastatic-melanoma/

Immunotherapy has dramatically improved melanoma survival rates. In this week's MedBlog, Terry Hart tells his story of surviving advanced melanoma through immunotherapy.

A breakthrough in Type 1 diabetes: What it might mean for children | Diet and Nutrition | Digestive | Pediatrics | UT Southwestern Medical Center

https://utswmed.org/medblog/prevent-t1d-teplizumab-study/

Teplizumab, a Type 1 diabetes immunotherapy drug, has been proven to slow onset of the disease by 2 years. This landmark discovery could lead to potential reduction in long-term health risks related to diabetes. Find out how the drug works and who might benefit in this week’s MedBlog. Learn more.

Search